D961H
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for D961H, covering 2010-09-21 to 2015-08-14. Get the full timeline:
Most recent: Clinical Trial Update: Compare D961H 20 mg Bid and 20 mg qd in Patients With Refractory Reflux Esophagitis (Inflammation of Lower Esophagus) [Phase 3]